Kyverna Therapeutics, Inc. announced that it expects to receive $25 million in funding from Vida Ventures Advisors, LLC, Westlake Village BioPartners, Gilead Sciences, Inc.
On the same date company received $25 million in its first tranche.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
65.68 USD | -0.74% | -3.01% | -18.92% |
1st Jan change | Capi. | |
---|---|---|
-18.92% | 81.83B | |
+38.51% | 727B | |
+31.74% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |